ES373377A1 - Procedimiento para la obtencion de quinalozinonas. - Google Patents

Procedimiento para la obtencion de quinalozinonas.

Info

Publication number
ES373377A1
ES373377A1 ES373377A ES373377A ES373377A1 ES 373377 A1 ES373377 A1 ES 373377A1 ES 373377 A ES373377 A ES 373377A ES 373377 A ES373377 A ES 373377A ES 373377 A1 ES373377 A1 ES 373377A1
Authority
ES
Spain
Prior art keywords
quinazolinones
aryl
substituted
pharmaceutical agents
quinazolinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES373377A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES373377A1 publication Critical patent/ES373377A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES373377A 1968-11-12 1969-11-10 Procedimiento para la obtencion de quinalozinonas. Expired ES373377A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00775201A US3723432A (en) 1968-11-12 1968-11-12 1-substituted-4-aryl-2(1h)-quinazolinones and their preparation

Publications (1)

Publication Number Publication Date
ES373377A1 true ES373377A1 (es) 1972-05-16

Family

ID=25103642

Family Applications (1)

Application Number Title Priority Date Filing Date
ES373377A Expired ES373377A1 (es) 1968-11-12 1969-11-10 Procedimiento para la obtencion de quinalozinonas.

Country Status (19)

Country Link
US (2) US3723432A (enEXAMPLES)
AT (4) AT319949B (enEXAMPLES)
BE (1) BE741529A (enEXAMPLES)
BG (10) BG16042A3 (enEXAMPLES)
BR (1) BR6914095D0 (enEXAMPLES)
CH (1) CH521972A (enEXAMPLES)
DE (1) DE1956384C3 (enEXAMPLES)
DK (1) DK129347B (enEXAMPLES)
ES (1) ES373377A1 (enEXAMPLES)
FR (1) FR2024830B1 (enEXAMPLES)
GB (1) GB1282612A (enEXAMPLES)
IE (1) IE33933B1 (enEXAMPLES)
IL (1) IL33348A (enEXAMPLES)
NL (1) NL6916514A (enEXAMPLES)
NO (1) NO124032B (enEXAMPLES)
OA (1) OA03829A (enEXAMPLES)
PL (1) PL72695B1 (enEXAMPLES)
SE (2) SE376917B (enEXAMPLES)
ZA (1) ZA697910B (enEXAMPLES)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923803A (en) * 1968-07-18 1975-12-02 Sumitomo Chemical Co 2(1H)-Quinozalinones and process therefor
US3642791A (en) * 1969-08-13 1972-02-15 Sandoz Ag Morpholino-1-substituted-2(1h)-quinazolinones
US4208343A (en) * 1970-10-30 1980-06-17 Westinghouse Electric Corp. 2,4 Diamino benzonitrile
BE785937A (fr) * 1971-07-08 1973-01-08 Sandoz Sa Nouveaux derives de la quinazoline, leur preparation et leur application comme medicaments
US3937705A (en) * 1972-03-09 1976-02-10 Sandoz, Inc. 1-isopropyl-7-methyl-4-(p-fluorophenyl)-2(1h)-quinazolinone
US4064246A (en) * 1976-10-12 1977-12-20 Sandoz, Inc. Hydroxymethyl-substituted-2(1H)-quinazolinones
US4071516A (en) * 1976-08-20 1978-01-31 Sandoz, Inc. 4-(Acyloxyphenyl)-quinazolin-2(1H)-ones
US4160092A (en) * 1977-06-16 1979-07-03 E. I. Du Pont De Nemours And Company Quinazolinone oxides and their use as intermediates for pharmaceutical agents
US4224328A (en) * 1979-04-11 1980-09-23 Sandoz, Inc. Methods with 1-substituted-4-aryl-quinazolin-2(1H)-ones and thiones and pyrido[2,3-d]pyrimidin-2-ones as platelet aggregation inhibitors
CH645362A5 (de) * 1979-07-05 1984-09-28 Sandoz Ag Verfahren zur herstellung von 4-phenyl-2(1h)-chinazolinonen.
FR2676042B1 (fr) * 1991-05-02 1993-07-23 Commissariat Energie Atomique Procede de preparation d'un borohydrure de metal alcalin tel que le borohydrure de lithium.
US6545004B1 (en) * 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
AR038658A1 (es) * 2001-06-15 2005-01-26 Novartis Ag Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
AU2002346471A1 (en) * 2001-11-20 2003-06-10 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
CA2475879A1 (en) * 2002-02-15 2003-08-28 Cytokinetics, Inc. Synthesis of quinazolinones
WO2003097053A1 (en) 2002-05-09 2003-11-27 Cytokinetics, Inc. Compounds, compositions, and methods
US7166595B2 (en) * 2002-05-09 2007-01-23 Cytokinetics, Inc. Compounds, methods and compositions
EP1513820A4 (en) * 2002-05-23 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
AU2003236527A1 (en) * 2002-06-14 2003-12-31 Cytokinetics, Inc. Compounds, compositions, and methods
US7211580B2 (en) * 2002-07-23 2007-05-01 Cytokinetics, Incorporated Compounds, compositions, and methods
AU2003262747A1 (en) * 2002-08-21 2004-03-11 Cytokinetics, Inc. Compounds, compositions, and methods
EP1558083A4 (en) * 2002-09-30 2008-04-16 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
GB0230015D0 (en) * 2002-12-23 2003-01-29 Novartis Ag Organic compounds
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
JP2007510652A (ja) * 2003-11-03 2007-04-26 サイトキネティクス・インコーポレーテッド ピリミジン−４−オン化合物、組成物、および方法
WO2005046588A2 (en) * 2003-11-07 2005-05-26 Cytokinetics, Inc. Compounds, compositions, and methods
US7439254B2 (en) * 2003-12-08 2008-10-21 Cytokinetics, Inc. Compounds, compositions, and methods
EP2173724B1 (en) * 2007-06-22 2012-12-05 ArQule, Inc. Quinazolinone compounds and methods of use thereof
US8058469B2 (en) * 2008-11-03 2011-11-15 Sabic Innovative Plastics Ip B.V. Method for making carbamates, ureas and isocyanates
EP2329849B1 (en) 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
US8394800B2 (en) * 2009-11-19 2013-03-12 Galderma Laboratories, L.P. Method for treating psoriasis
WO2011117378A2 (en) 2010-03-26 2011-09-29 Galderma Research & Development Improved methods and compositions for safe and effective treatment of telangiectasia
KR101707704B1 (ko) 2010-03-26 2017-02-16 갈데르마 리써어치 앤드 디벨로프먼트 홍반의 유효하고 안전한 치료를 위한 개선된 방법 및 조성물
BR112013009578B1 (pt) 2010-10-21 2020-10-20 Galderma S.A. composição tópica em gel e uso de uma composição tópica em gel
US8053427B1 (en) 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452041A (en) * 1965-05-19 1969-06-24 American Home Prod Hydantoin compounds and methods of preparation

Also Published As

Publication number Publication date
BG16042A3 (bg) 1972-05-20
IL33348A0 (en) 1970-01-29
DK129347B (da) 1974-09-30
BG15573A3 (bg) 1976-06-26
AT310169B (de) 1973-09-25
BG16038A3 (bg) 1972-05-20
BG16040A3 (bg) 1972-05-20
BG16039A3 (bg) 1972-05-20
USB313531I5 (enEXAMPLES) 1975-01-28
IE33933L (en) 1970-05-12
FR2024830B1 (enEXAMPLES) 1973-07-13
ZA697910B (en) 1971-07-28
SE374920B (enEXAMPLES) 1975-03-24
DK129347C (enEXAMPLES) 1975-02-17
OA03829A (fr) 1971-12-24
IL33348A (en) 1973-04-30
BE741529A (enEXAMPLES) 1970-05-11
BG16036A3 (bg) 1972-05-20
US3925548A (en) 1975-12-09
SE376917B (enEXAMPLES) 1975-06-16
BR6914095D0 (pt) 1973-02-13
BG16037A3 (bg) 1972-05-20
US3723432A (en) 1973-03-27
BG16041A3 (bg) 1972-05-20
FR2024830A1 (enEXAMPLES) 1970-09-04
AT319949B (de) 1975-01-10
IE33933B1 (en) 1974-12-11
AT310176B (de) 1973-09-25
SU366612A3 (enEXAMPLES) 1973-01-16
PL72695B1 (en) 1974-08-30
DE1956384C3 (de) 1980-10-09
AT319950B (de) 1975-01-10
DE1956384A1 (de) 1970-06-11
GB1282612A (en) 1972-07-19
NL6916514A (enEXAMPLES) 1970-05-14
NO124032B (enEXAMPLES) 1972-02-21
BG16043A3 (bg) 1972-05-20
DE1956384B2 (de) 1980-02-07
CH521972A (de) 1972-04-30
BG16188A3 (bg) 1972-07-20

Similar Documents

Publication Publication Date Title
ES373377A1 (es) Procedimiento para la obtencion de quinalozinonas.
AU471598B2 (en) 2-amidazolin 2-ylamino substituted quinoxaline and quinazolines as antihypertensive agents
CH548736A (de) Herbizid und verwendung desselben.
SE402283B (sv) Karbazoler med antiinflammatorisk, analgetisk och antireumatisk verkan
DK115114B (da) Fremgangsmåde til fremstilling af bakteriostatisk og fungistatisk virksomme 1,2,3,4-tetrahydro-9-aminoacridiner.
PH9276A (en) 3,4-dihydro-2(1h)-quinazolinones
DK127332B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 1-substituerede 2[1H]-quinazolinoner.
BE765533A (fr) Nouvelles isoxazolo-pyrimidines et leur application comme herbicides
JPS5598103A (en) Novel quinazolinone herbicide
DK130115B (da) Analogifremgangsmåde til fremstilling af 1-substituerede 2(1H)-quinazolinoner.
SU444367A3 (ru) Способ получения 2(1н)хиназолинонов
DK129350B (da) Fremgangsmåde til fremstilling af 1-substituerede 2(1H)-quinazolinonderivater.
IE35594B1 (en) N-(bicycloamino-alkanoyl)-anilines
CH465724A (de) Anodenplatte und ihre Verwendung
CH419526A (it) Procedimento per la costruzione di costruzioni edili
FR1413359A (fr) Perfectionnements à la construction des lampes fluorescentes
CH468457A (de) Rotlumineszierendes Stoffgemisch und dessen Verwendung
ES366209A1 (es) Metodo de preparacion de un compuesto pesticida.
DK120545B (da) Analogifremgangsmåde til fremstilling af 2-methoxy-4-(N<4>-glutarylsulfanilamido)-quinazolin eller farmaceutisk uskadelige metalsalte deraf.
FR1405935A (fr) Perfectionnement apporté aux panneaux publicitaires plus spécialement utilisables le long des axes routiers
CA688318A (en) Steel shelving construction
ES142271Y (es) Pabellon para exhibicion de espectaculo publico ambulante.
DK127187B (da) Analogifremgangsmåde til fremstilling af 1-propargyl-4-phenyl-2(1H)-quinazolinoner.
AU463486B2 (en) Substituted uretidine-2, 4-diones and their use as herbicides
FI41554C (fi) Sätt att framställa farmakologiskt värdefulla 4-amino-6,7-di(lägre)alkoksikinoliner